There are no clinical studies that have shown caffeine to be detrimental to PRP therapy, but there are some reasons to expect that it may have an impact. One reason is the effect of coffee on platelet function. For example, coffee drinking has been shown to inhibit platelet aggregation, which is crucial in thrombotic events and plays a role in cardiovascular disease (CVD). A study found that coffee consumption significantly inhibited platelet aggregation induced by collagen and arachidonic acid, while caffeine alone had no significant effect. This suggests that the phenolic compounds in coffee, rather than caffeine, may interfere with platelet function (Natella et al., 2008). Here’s why:
To ensure you receive the maximum benefits from your PRP therapy, adhere to the following guidelines regarding caffeine:
Working with a qualified professional ensures you receive personalized care tailored to your needs. It is essential to understand how lifestyle choices affect PRP therapy outcomes.
Educational Approach:
Caffeine’s effects on the body are well-documented in scientific literature. Its impact on platelet function and vascular dynamics can be particularly detrimental in the context of PRP therapy.
Maximizing the benefits of PRP therapy involves more than just the procedure itself; it’s about understanding and adhering to guidelines that enhance healing and tissue regeneration. Avoiding caffeine before and after your treatment is a simple yet effective way to ensure you achieve the best possible outcomes.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional for personalized recommendations.
Gupta, A.K., & Carviel, J.L. (2017). A Mechanistic Review of Platelet Rich Plasma for Hair Loss. Dermatologic Surgery, 43(6), 750–758. ↩
Picard, F., Hersant, B., Bosc, R., & Meningaud, J.P. (2015). The Growing Evidence for the Use of Platelet-Rich Plasma on Irradiated Tissues: A Review and a Proposal for the Use of Platelet-Rich Plasma Gel. Wound Repair and Regeneration, 23(1), 66–71. ↩
Marx, R.E. (2004). Platelet-Rich Plasma: Evidence to Support Its Use. Journal of Oral and Maxillofacial Surgery, 62(4), 489–496. ↩
Alves, R., & Grimalt, R. (2018). A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification. Skin Appendage Disorders, 4(1), 18–24. ↩
López-Farré, A.J., & Alberca, M.T. (1994). Effects of Caffeine on Platelet Function. Thrombosis Research, 76(4), 383–388. ↩
Nawrot, P., Jordan, S., Eastwood, J., Rotstein, J., Hugenholtz, A., & Feeley, M. (2003). Effects of Caffeine on Human Health. Food Additives & Contaminants, 20(1), 1–30. ↩
Nehlig, A. (2016). Effects of Coffee/Caffeine on Brain Health and Disease: What Should I Tell My Patients? Practical Neurology, 16(2), 89–95. ↩
Fisher, J.P., & Kim, A. (2014). Caffeine and the Central Nervous System: Mechanisms of Action, Biochemical, Metabolic and Psychostimulant Effects. Critical Reviews in Food Science and Nutrition, 54(4), 483–592. ↩
Armstrong, L.E. (2002). Caffeine, Body Fluid-Electrolyte Balance, and Exercise Performance. International Journal of Sport Nutrition and Exercise Metabolism, 12(2), 189–206. ↩
Popkin, B.M., D’Anci, K.E., & Rosenberg, I.H. (2010). Water, Hydration and Health. Nutrition Reviews, 68(8), 439–458. ↩
American Society of Plastic Surgeons. (n.d.). Platelet-Rich Plasma (PRP). Retrieved from https://www.plasticsurgery.org/ ↩
Mayo Clinic Staff. (2020). Platelet-Rich Plasma (PRP) Therapy. Mayo Clinic. Retrieved from https://www.mayoclinic.org/ ↩
Institute of Medicine (US) Panel on Dietary Reference Intakes for Electrolytes and Water. (2005). Dietary Reference Intakes for Water. National Academies Press (US). ↩
Steiner, J.L., & Lang, C.H. (2017). Alcohol, Adipose Tissue and Lipid Dysregulation. Biomolecules, 7(4), 82. ↩
Sopori, M. (2002). Effects of Cigarette Smoke on the Immune System. Nature Reviews Immunology, 2(5), 372–377. ↩
Warner, T.D., & Mitchell, J.A. (2008). Cyclooxygenases: New Forms, New Inhibitors, and Lessons from the Clinic. FASEB Journal, 18(7), 790–804. ↩
Maffulli, N., & Longo, U.G. (2010). Conservative Management for Tendinopathy: Is There Enough Scientific Evidence? Rheumatic Disease Clinics of North America, 36(2), 443–460. ↩
Michelson, A.D. (2011). Platelets (3rd ed.). Academic Press. ↩
Smits, P., Boekema, P., De Abreu, R., Thien, T., & van ‘t Laar, A. (1987). Evidence for an Intravascular Adenosine Mechanism in Caffeine Tolerance in Humans. Journal of Cardiovascular Pharmacology, 10(2), 136–143. ↩
Rudolph, E., & Knoll, K. (2009). Content of Caffeine in Coffee and Energy Drinks and Its Implications for Estimates of Dietary Caffeine Intake. Food and Chemical Toxicology, 47(3), 553–558. ↩
Peters, E.M., Foitzik, K., Paus, R., & Langan, E.A. (2017). Hair Growth Modulation by Herbal and Synthesized Molecules. Current Pharmaceutical Design, 23(14), 2128–2144. ↩
Khatu, S.S., More, Y.E., Gokhale, N.R., Chavhan, D.C., & Bendsure, N. (2014). Platelet-Rich Plasma in Androgenic Alopecia: Myth or an Effective Tool. Journal of Cutaneous and Aesthetic Surgery, 7(2), 107–110. ↩
Daniel Zengel, an executive with over 10 years of experience in the pharmaceutical and medical device space, is dedicated to delivering industry-leading, cost-effective products to US-based medical providers. Specializing in regenerative medicine, Daniel focuses on sales, training, and marketing support to help clinics across the country successfully implement platelet-rich plasma (PRP) therapy.
*We Typically Call Within 15 Minutes
Whether you are interested in offering PRP for aesthetic or musculoskeletal indications, we will provide you with everything you need to get great outcomes while increasing revenue!